Genomic Health Stock
Your prediction
Pros and Cons of Genomic Health in the next few years
Pros
?
S********** s********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genomic Health vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genomic Health | - | - | - | - | - | - | - |
| Iovance Biotherapeutics Inc. | 4.680% | 12.764% | 10.159% | -55.523% | 3.541% | -64.057% | -92.656% |
| United Therapeutics | 0.650% | 1.411% | 1.462% | 16.570% | -5.827% | 71.746% | 183.380% |
| Neurocrine Bioscience | -0.830% | 3.863% | -5.469% | -5.633% | -10.774% | 13.402% | 21.649% |